Bank of America’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.8K | Buy |
9,943
+4,473
| +82% | +$34.1K | ﹤0.01% | 5662 |
|
|
2025
Q1 | $17.8K | Sell |
5,470
-9,573
| -64% | -$31.2K | ﹤0.01% | 5968 |
|
|
2024
Q4 | $67.7K | Sell |
15,043
-525,394
| -97% | -$2.36M | ﹤0.01% | 5660 |
|
|
2024
Q3 | $1.5M | Buy |
540,437
+45,411
| +9% | +$126K | ﹤0.01% | 4039 |
|
|
2024
Q2 | $1.69M | Buy |
495,026
+237,805
| +92% | +$813K | ﹤0.01% | 3870 |
|
|
2024
Q1 | $1.39M | Buy |
257,221
+240,540
| +1,442% | +$1.3M | ﹤0.01% | 3956 |
|
|
2023
Q4 | $90.4K | Buy |
16,681
+3,695
| +28% | +$20K | ﹤0.01% | 5487 |
|
|
2023
Q3 | $114K | Buy |
+12,986
| New | +$114K | ﹤0.01% | 5325 |
|